Soquelitinib
CPI-818-004
Phase 3 small_molecule active
Quick answer
Soquelitinib for Peripheral T-Cell Lymphoma, Not Otherwise Specified is a Phase 3 program (small_molecule) at Corvus Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Corvus Pharmaceuticals
- Indication
- Peripheral T-Cell Lymphoma, Not Otherwise Specified
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active